Proposed Pathway Linking Respiratory Infections with Depression

키워드

참고문헌 (67)

1. Chaves Filho AJM, "IDO chronic immune activation and tryptophan metabolic pathway : a potential pathophysiological link between depression and obesity", Prog Neuropsychopharmacol Biol Psychiatry, 80(Pt C), pp.234~249 (2018)
2. Lopez AD, "Measuring the global burden of disease and epidemiological transitions : 2002-2030", Ann Trop Med Parasitol, 100, pp.481~499 (2006)
3. Kessler RC, "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.617~627 (2005)
4. Mann JJ, "Neurobiology of suicidal behaviour", Nat Rev Neurosci, 4, pp.819~828 (2003)
5. Okusaga O, "Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts", J Affect Disord, 130, pp.220~225 (2011)
6. Postolache TT, "Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders", J Affect Disord, 121, pp.88~93 (2010)
7. Dantzer R, "Cytokines and depression : fortuitous or causative association?", Mol Psychiatry, 4, pp.328~332 (1999)
8. Liu W, "Swimming exercise ameliorates depression-like behavior in chronically stressed rats : relevant to proinflammatory cytokines and IDO activation", Behav Brain Res, 242, pp.110~116 (2013)
9. Miller AH, "Inflammation and its discontents : the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
10. Troy NM, "Respiratory viral infections and host responses;insights from genomics", Respir Res, 17, pp.156~ (2016)
11. Mahony JB, "Molecular diagnosis of respiratory virus infections", Crit Rev Clin Lab Sci, 48, pp.217~249 (2011)
12. Zhang N, "Recent advances in the detection of respiratory virus infection in humans", J Med Virol, 92, pp.408~417 (2020)
13. "4 million deaths caused annually by acute respiratory infections" (2020)[URL]
14. Thompson WW, "Influenza-associated hospitalizations in the United States", JAMA, 292, pp.1333~1340 (2004)
15. Meskill SD, "Respiratory virus co-infection in acute respiratory infections in children", Curr Infect Dis Rep, 22, pp.3~ (2020)
16. Murray RS, "Coronaviruses and their diseases", pp.505~510 (1990), Springer US
17. Chenari M, "SARS-CoV-2 as emerging disease : preventive instructions and review of literature", Int J Trop Med, 15, pp.103~108 (2020)
18. Bouças AP, "Why severe COVID-19patients are at greater risk of developing depression : a molecular perspective", Neuroscientist (2020)[DOI]
19. Newton AH, "The host immune response in respiratory virus infection : balancing virus clearance and immunopathology", Semin Immunopathol, 38, pp.471~482 (2016)
20. See H, "Innate immune response to viral infection of the lungs", Paediatr Respir Rev, 9, pp.243~250 (2008)
21. Katze MG, "Viruses and interferon : a fight for supremacy", Nat Rev Immunol, 2, pp.675~687 (2002)
22. Samuel CE, "Antiviral actions of interferons", Clin Microbiol Rev, 14, pp.778~809 (2001)
23. Crouse J, "Regulation of antiviral T cell responses by type I interferons", Nat Rev Immunol, 15, pp.231~242 (2015)
24. Coro ES, "Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection", J Immunol, 176, pp.4343~4351 (2006)
25. Jones SA, "Directing transition from innate to acquired immunity : defining a role for IL-6", J Immunol, 175, pp.3463~3468 (2005)
26. Teijaro JR, "The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options", Curr Top Microbiol Immunol, 386, pp.3~22 (2015)
27. Bilir C, "Indoleamine 2, 3-dioxygenase(IDO) : only an enzyme or a checkpoint controller?", J Oncol Sci, 3, pp.52~56 (2017)
28. Ball HJ, "Characterization of an indoleamine 2, 3-dioxygenase-like protein found in humans and mice", Gene, 396, pp.203~213 (2007)
29. Panozzo C, "Aerobic and anaerobic NAD+ metabolism in Saccharomyces cerevisiae", FEBS Lett, 517, pp.97~102 (2002)
30. Qin Y, "IDO and TDO as a potential therapeutic target in different types of depression", Metab Brain Dis, 33, pp.1787~1800 (2018)
31. Yamamoto Y, "Lipopolysaccharide shock reveals the immune function of indoleamine 2, 3-dioxygenase 2 through the regulation of IL-6", stat3 signalling, 2018, pp.8, 15917~
32. Mellor AL, "Indoleamine 2, 3-dioxygenase and tolerance : where are we now?", Front Immunol, 8, pp.1360~ (2017)
33. Aronson JK, "Meyler’s side effects of drugs", pp.220~221 (2016), Elsevier
34. Rodriguez Cetina Biefer H, "Aspects of tryptophan and nicotinamide adenine dinucleotide in immunity : a new twist in an old tale", Int J Tryptophan Res, 10, pp.1178646917713491~ (2017)
35. Richard DM, "L-tryptophan : basic metabolic functions, behavioral research and therapeutic indications", Int J Tryptophan Res, 2, pp.45~60 (2009)
36. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015", Lancet, 388, pp.1545~1602 (2016)
37. Shih-Hsien Lin, "Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence", Clinical Psychopharmacology and Neuroscience, 12(3), pp.196~202 (2014), 대한정신약물학회
38. Marazziti D, "Understanding the role of serotonin in psychiatric diseases", F1000Res, 6, pp.180~ (2017)
39. "Serotonin: 9 questions and answers" (2011)[URL]
40. So Hee Lee, "Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors", PSYCHIATRY INVESTIGATION, 16(1), pp.59~64 (2019), 대한신경정신의학회[DOI]
41. Wang J, "Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice", Nat Commun, 9, pp.477~ (2018)
42. Sailer V, "DNA methylation of indoleamine 2, 3-dioxygenase 1(IDO1)in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature", EBioMedicine, 48, pp.341~352 (2019)
43. Rakofsky JJ, "Nothing to sneeze at : upper respiratory infections and mood disorders", Curr Psychiatry, 18, pp.29~34 (2019)
44. Mazza MG, "Anxiety and depression in COVID-19 survivors : role of inflammatory and clinical predictors", Brain Behav Immun, 89, pp.594~600 (2020)
45. Guo Q, "Immediate psychological distress in quarantined patients with COVID-19and its association with peripheral inflammation : a mixedmethod study", Brain Behav Immun, 88, pp.17~27 (2020)
46. Coughlin SS, "Anxiety and depression : linkages with viral diseases", Public Health Rev, 34, pp.7~ (2012)
47. Zhang R, "The negative psychology for the public in Zhejiang province during the epidemic of human H7N9 avian influenza", Zhonghua Yu Fang Yi Xue Za Zhi, 49, pp.1073~1079 (2015)
48. Bornand D, "The risk of new onset depression in association with influenza--a population-based observational study", Brain Behav Immun, 53, pp.131~137 (2016)
49. Glaser R, "Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults", Arch Gen Psychiatry, 60, pp.1009~1014 (2003)
50. Malhotra S, "Viral infections and depression", Delhi Psychiatry J, 15, pp.188~195 (2012)
51. Carenzo L, "Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19", Ann Intensive Care, 11, pp.91~ (2021)
52. Hurissi E, "Assessment of new-onset depression and anxiety associated with COVID-19", Middle East Curr Psychiatry, 28, pp.33~ (2021)
53. Ismael F, "Post-infection depressive, anxiety and post-traumatic stress symptoms : a prospective cohort study in patients with mild COVID-19", Prog Neuropsychopharmacol Biol Psychiatry, 111, pp.110341~ (2021)
54. Capuron L, "Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism : role in neuropsychiatric symptoms", Biol Psychiatry, 70, pp.175~182 (2011)
55. Raison CL, "Cytokines sing the blues : inflammation and the pathogenesis of depression", Trends Immunol, 27, pp.24~31 (2006)
56. Myint AM, "Cytokine-serotonin interaction through IDO : a neurodegeneration hypothesis of depression", Med Hypotheses, 61, pp.519~525 (2003)
57. Wichers MC, "The role of indoleamine 2, 3-dioxygenase(IDO)in the pathophysiology of interferon-alpha-induced depression", J Psychiatry Neurosci, 29, pp.11~17 (2004)
58. Koo JW, "IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress", Proc Natl Acad Sci U S A, 105, pp.751~756 (2008)
59. Hughes MM, "Stress-related immune markers in depression : implications for treatment", Int J Neuropsychopharmacol, 19, pp.pyw001~ (2016)
60. Williams M, "Maternal inflammation results in altered tryptophan metabolism in rabbit placenta and fetal brain", Dev Neurosci, 39, pp.399~412 (2017)
61. Maes M, "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways", BMC Med, 10, pp.66~ (2012)
62. Mayhew J, "Astrocyte and microglial control of glutamatergic signalling : a primer on understanding the disruptive role of chronic stress", J Neuroendocrinol, 27, pp.498~506 (2015)
63. Maes M, "Depression is an inflammatory disease, but cellmediated immune activation is the key component of depression", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.664~675 (2011)
64. Quak J, "Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?", Psychoneuroendocrinology, 45, pp.202~210 (2014)
65. Kruse JL, "Kynurenine metabolism and inflammation-induced depressed mood : a human experimental study", Psychoneuroendocrinology, 109, pp.104371~ (2019)
66. Fritsch SD, "Effects of interferons and viruses on metabolism", Front Immunol, 7, pp.630~ (2016)
67. Ogbechi J, "IDO activation, inflammation and musculoskeletal disease", Exp Gerontol, 131, pp.110820~ (2020)

관련 논문AI추천